These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients. Kahwaji J; Barker E; Pepkowitz S; Klapper E; Villicana R; Peng A; Chang R; Jordan SC; Vo AA Clin J Am Soc Nephrol; 2009 Dec; 4(12):1993-7. PubMed ID: 19833910 [TBL] [Abstract][Full Text] [Related]
7. Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment. Gerber S; Gaida A; Spiegl N; Wymann S; Antunes AM; Menyawi IE; Zurbriggen B; Hubsch A; Imboden M BioDrugs; 2016 Oct; 30(5):441-451. PubMed ID: 27646589 [TBL] [Abstract][Full Text] [Related]
8. Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti-blood group A and B antibodies and individual susceptibility. Mielke O; Fontana S; Goranova-Marinova V; Shebl A; Spycher MO; Wymann S; Durn BL; Lawo JP; Hubsch A; Salama A Transfusion; 2017 Nov; 57(11):2629-2638. PubMed ID: 28840942 [TBL] [Abstract][Full Text] [Related]
9. Isoagglutinin-reduced immunoglobulin retains efficacy in mouse models of immune thrombocytopenia and rheumatoid arthritis and is less likely to cause intravenous immunoglobulin-associated hemolysis. Cen SY; Branch DR Transfusion; 2020 Feb; 60(2):250-255. PubMed ID: 31837028 [TBL] [Abstract][Full Text] [Related]
10. Hemolytic adverse effects of intravenous immunoglobulin: modeling predicts risk reduction with anti-A/B immunoaffinity chromatography and to a lesser extent with anti-A donor screening. Mallick R; Hubsch A; Barnes DG Transfusion; 2018 Dec; 58(12):2752-2756. PubMed ID: 30284263 [TBL] [Abstract][Full Text] [Related]
11. Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions: an analysis of spontaneous adverse event reports. Shebl A; Gabriel S; Van Dinther K; Hubsch A; Lawo JP; Hoefferer L; Welsh S Transfusion; 2020 Jun; 60(6):1278-1286. PubMed ID: 32410287 [TBL] [Abstract][Full Text] [Related]
12. Role of Fc fragments in inhibition of xenogenic hyperacute rejection by intravenous immunoglobulin. Kojima T; Hayashi S; Yokoyama I; Takagi H Transplantation; 1996 Sep; 62(5):559-62. PubMed ID: 8830815 [TBL] [Abstract][Full Text] [Related]
13. Isoagglutinin Reduction in Human Immunoglobulin Products by Donor Screening. Siani B; Willimann K; Wymann S; Marques AA; Widmer E Biol Ther; 2014 Dec; 4(1-2):15-26. PubMed ID: 24841428 [TBL] [Abstract][Full Text] [Related]
14. Hemolytic anemia associated with intravenous immunoglobulin. Wilson JR; Bhoopalam H; Fisher M Muscle Nerve; 1997 Sep; 20(9):1142-5. PubMed ID: 9270670 [TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors for intravenous immunoglobulin-related hemolysis: A systematic review of clinical trial and real-world populations. Cuesta H; El Menyawi I; Hubsch A; Hoefferer L; Mielke O; Gabriel S; Shebl A Transfusion; 2022 Sep; 62(9):1894-1907. PubMed ID: 35916266 [TBL] [Abstract][Full Text] [Related]
16. Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes. Michelis FV; Branch DR; Scovell I; Bloch E; Pendergrast J; Lipton JH; Cserti-Gazdewich CM Transfusion; 2014 Mar; 54(3):681-90. PubMed ID: 23829192 [TBL] [Abstract][Full Text] [Related]
17. Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products. Bruggeman CW; Nagelkerke SQ; Lau W; Manlhiot C; de Haas M; van Bruggen R; McCrindle BW; Yeung RSM; Kuijpers TW Blood Adv; 2020 Jul; 4(14):3416-3426. PubMed ID: 32722782 [TBL] [Abstract][Full Text] [Related]
18. Effects of the manufacturing process on the anti-A isoagglutinin titers in intravenous immunoglobulin products. Romberg V; Hoefferer L; El Menyawi I Transfusion; 2015 Jul; 55 Suppl 2():S105-9. PubMed ID: 26174887 [TBL] [Abstract][Full Text] [Related]
19. Do immune complexes play a role in hemolytic sequelae of intravenous immune globulin? Zimring JC Transfusion; 2015 Jul; 55 Suppl 2():S86-9. PubMed ID: 26174903 [TBL] [Abstract][Full Text] [Related]
20. Isoagglutinin reduction by a dedicated immunoaffinity chromatography step in the manufacturing process of human immunoglobulin products. Hoefferer L; Glauser I; Gaida A; Willimann K; Marques Antunes A; Siani B; Wymann S; Widmer E; El Menyawi I; Bolli R; Spycher M; Imboden M Transfusion; 2015 Jul; 55 Suppl 2():S117-21. PubMed ID: 26174889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]